Phenol injections work by chemically destroying nerve tissue to block pain signals, offering relief that typically lasts anywhere from two months to a year. Used since the mid-twentieth century, phenol remains one of the least expensive tools in interventional pain management, yet it occupies a surprisingly niche place in modern practice. The procedure is quick, can be repeated, and covers a range of conditions from cancer pain to muscle spasticity to stubborn foot neuromas, but it comes with trade-offs that are worth understanding before you agree to one.
How Phenol Destroys Nerve Tissue
When a clinician injects phenol near a nerve, the chemical breaks down the proteins that hold nerve cells together. It strips the protective myelin coating away from the nerve fiber, causes the fiber itself to swell, and dissolves the cells responsible for maintaining that coating. The result is a stretch of nerve that can no longer transmit pain signals effectively.1Journal of Pain Research. A Review of Nonsurgical Neurolytic Procedures for Neuropathic Pain This destruction is not permanent. Nerves begin attempting to regrow their fibers within hours of the injury, and over the following weeks to months, function gradually returns. That built-in expiration date is actually part of the appeal for certain conditions, as we will see, but it also means phenol is rarely a one-and-done solution.
Concentrations used in clinical practice usually range from about 3% to 7% in water or glycerol. Higher concentrations destroy more tissue but carry greater risk of collateral damage. The solution works on contact, so precise placement matters enormously. At low concentrations phenol actually has a brief local anesthetic effect before the neurolytic damage kicks in, which is why some patients feel temporary numbness followed by a burning sensation during the injection.
Where Phenol Injections Are Used
Phenol injections show up across several branches of medicine, each exploiting the same nerve-destroying property for different goals. The three main arenas are cancer-related pain, muscle spasticity, and focal nerve pain like Morton’s neuroma or stump neuromas. Understanding the specific application helps make sense of why a doctor might recommend phenol over other options.
Cancer Pain
One of the oldest and most established uses is celiac plexus neurolysis for upper abdominal cancer pain, particularly in pancreatic cancer. The celiac plexus is a bundle of nerves near the stomach and pancreas that carries visceral pain signals. Destroying it with phenol can dramatically reduce the need for opioids. A pilot study in patients with upper gastrointestinal cancers found that phenol-based celiac plexus neurolysis dropped median pain scores from 5 to 1.5 within two hours, and that level held at the 24-hour mark.2PubMed Central. Phenol-based endoscopic ultrasound-guided celiac plexus neurolysis for East Asian alcohol-intolerant upper gastrointestinal cancer patients: a pilot study The procedure is considered safe and effective enough that guidelines recommend considering it early, not just as a last resort.3PubMed Central. Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal Pain
Spasticity
Phenol nerve blocks are a workhorse treatment for the tight, involuntary muscle contractions that follow brain injuries, strokes, and spinal cord injuries. In the early months after an injury, spasticity tends to be at its worst and can prevent therapists from moving a patient’s limbs through their range of motion. Phenol provides a temporary block lasting weeks to months, buying time for rehabilitation while the nervous system stabilizes.4PubMed. Treatment of acquired muscle spasticity using phenol peripheral nerve blocks A systematic review found that phenol neurolysis typically improves spasticity by one to two grades on the standard clinical scale, with effects lasting three to six months and often outlasting botulinum toxin injections.5PubMed. Indications, Trends, and Outcomes of Nerve Blocks for Spasticity Management: A Systematic Review
Morton’s Neuroma and Stump Neuromas
Morton’s neuroma, a painful thickening of nerve tissue between the toes, can be treated with phenol injections as an alternative to surgery. A long-term study following 125 patients for an average of over eight years found that the treatment was successful (defined as more than a 50% drop in pain scores) in about 71% of cases, and fewer than 10% eventually needed surgery.6PubMed Central. Infiltrative Therapy of Morton’s Neuroma: a Systematic Review of Different Treatment Options An earlier series of 71 cases reported effective pain relief in about 80% of patients.7PubMed. Local phenol injection in the treatment of interdigital neuritis of the foot (Morton’s neuroma) For stump neuromas in amputees, ultrasound-guided phenol instillation has also shown promise. In one study of 80 patients, about 38% reported near-complete pain relief at six months, and roughly two-thirds said their pain at follow-up matched the best level they had reached during treatment.8PubMed. Practical experience with sonographically guided phenol instillation of stump neuroma: predictors of effects, success, and outcome
How the Procedure Works in Practice
You will not just get a blind injection. Modern phenol neurolysis almost always uses some form of guidance to make sure the chemical lands on the right nerve. The two most common tools are electrical stimulation and ultrasound, and many clinicians use both at the same time.
Electrical stimulation involves threading a needle near the target nerve and sending a small current through it. When the needle tip is close enough, the current triggers a visible muscle twitch or reproduces the patient’s symptoms, confirming placement. Ultrasound lets the clinician see the nerve and surrounding structures in real time. A study comparing electrical stimulation alone versus combined ultrasound and electrical stimulation for phenol neurolysis of the musculocutaneous nerve found that adding ultrasound reduced the amount of phenol needed (about 2.3 mL versus 3.7 mL) without sacrificing effectiveness.9PubMed Central. Comparing Electrical Stimulation With and Without Ultrasound Guidance for Phenol Neurolysis to the Musculocutaneous Nerve Lower doses mean less chemical floating around where it should not be, which translates to fewer side effects. For hip spasticity, a randomized trial showed that combining both guidance methods for obturator nerve blocks safely reduced adductor spasticity and improved hygiene and patient-centered outcomes in long-term care residents.10PubMed. Ultrasound and electrical stimulator-guided obturator nerve block with phenol in the treatment of hip adductor spasticity in long-term care patients
The injection itself is relatively fast. In spasticity clinics, multiple muscles are often treated in a single visit, especially when phenol is combined with botulinum toxin. Recovery is minimal: most people leave the clinic the same day, though some soreness, swelling, or temporary weakness at the injection site is common in the first few days.
How Long Does the Pain Relief Last
Phenol’s pain-relieving effect is fundamentally temporary because nerves regrow. The clinical window is roughly two to twelve months, with most patients landing somewhere in the three-to-six-month range.11PubMed Central. Phenol Neurolysis in Pain and Palliative Medicine Peripheral nerves are particularly good at regeneration. The regrowth process begins within 24 hours of the chemical injury, and immune cells move in within two to three days to clear debris and support new fiber growth.11PubMed Central. Phenol Neurolysis in Pain and Palliative Medicine
This wide range depends on several factors. Higher concentrations and larger volumes tend to produce longer-lasting blocks but also greater tissue damage. The specific nerve matters too; deeply seated nerves surrounded by protective tissue may regenerate differently than superficial ones. In cancer pain settings, the question of duration is often less pressing because the procedure may only need to last the remainder of a patient’s illness. For chronic non-cancer conditions like spasticity, the temporary nature means repeat injections become part of the treatment plan.
The Morton’s neuroma data offers an interesting exception. Because the goal there is to destroy a small, discrete chunk of nerve tissue, the relief can be functionally permanent for a good portion of patients. The eight-year follow-up study mentioned earlier found lasting benefit in a majority of cases.12PubMed. Can percutaneous alcoholization of Morton’s neuroma with phenol by electrostimulation guidance be an alternative to surgical excision? Long-term results
Risks and Side Effects
Phenol is not a gentle substance, and injecting it near nerves carries real risks. The most commonly discussed side effects are pain at the injection site, swelling, and dysesthesia, an unpleasant burning or tingling sensation that develops when the nerve regenerates abnormally. Reviews place the frequency of painful dysesthesia in the range of 3% to 10%, typically resolving within a few months to a year.13PubMed Central. Adverse Reactions to Phenol Neurolysis: Report of Severe Necrosis and Infection Following Genicular Nerve Ablation
A large retrospective review of 293 phenol neurolysis procedures for spasticity found a reassuringly low overall adverse event rate: pain in 4% of cases, swelling and inflammation in about 3%, and dysesthesia and low blood pressure each in under 1%.14PubMed. Practice patterns for spasticity management with phenol neurolysis Of those patients who had follow-up assessments, roughly 85% reported feeling that the procedure helped.14PubMed. Practice patterns for spasticity management with phenol neurolysis A study of phenol neurolysis for hand and forearm spasticity reported three cases of prolonged pain but no dysesthesia over a follow-up period of more than 40 days.15PubMed. Phenol Neurolysis for Management of Focal Spasticity in the Distal Upper Extremity
The risk profile changes sharply when something goes wrong with dosing or placement. A case report describes a patient who accidentally received an injection of 89% phenol instead of the intended clinical concentration, resulting in acute respiratory failure and kidney failure requiring a ventilator and dialysis.16PubMed. Acute phenol poisoning: a life-threatening hazard of chronic pain relief That scenario is extremely rare and represents a preparation error rather than a typical procedural risk. At standard clinical concentrations and volumes, systemic toxicity is not a realistic concern for most patients. A study of repeated phenol and botulinum toxin injections in children found no increase in complications with repeat treatments and no relationship between complication rates and dosage of either agent.17American Journal of Physical Medicine & Rehabilitation. Safety Profile of Multilevel Chemical Denervation Procedures Using Phenol or Botulinum Toxin or Both in a Pediatric Population
Phenol Versus Other Treatments
The two main alternatives you will hear about are botulinum toxin (Botox and its variants) and radiofrequency ablation. Each has a distinct profile, and the choice often depends on the condition being treated, cost considerations, and the specific nerves involved.
Phenol Versus Botulinum Toxin for Spasticity
Botulinum toxin is injected directly into the muscle and works by blocking the chemical signal at the junction between nerve and muscle. It wears off in about three to four months and has a well-established safety record. Phenol, by contrast, is injected near the nerve itself and physically destroys nerve fibers. In a head-to-head randomized trial for ankle spasticity after stroke, botulinum toxin produced faster and initially stronger improvements at weeks two and four, but by weeks eight and twelve there was no significant difference between the two treatments.18American Journal of Physical Medicine & Rehabilitation. Comparison of Phenol Block and Botulinus Toxin Type A in the Treatment of Spastic Foot After Stroke In children with cerebral palsy, a comparative study found botulinum toxin superior for reducing spasticity, improving range of motion, and functional outcomes, with fewer side effects.19PubMed Central. Phenol Versus Botulinum Toxin A Injection in Ambulatory Cerebral Palsy Spastic Diplegia: A Comparative Study
Where phenol shines is cost and the ability to treat many muscles at once. Botulinum toxin is expensive and has dose ceilings: inject too much across too many muscles and you risk systemic weakness. Clinicians frequently combine the two, using botulinum toxin in smaller or more superficial muscles and phenol for larger, deeper nerve targets. This combination approach lets providers treat widespread spasticity in a single session without exceeding safe botulinum toxin doses.20British Journal of Medical Practitioners. Combined Botulinum Toxin Injections and Phenol Nerve / Motor Point Blocks to Manage Multifocal Spasticity in Adults
Phenol Versus Radiofrequency Ablation for Knee Pain
Radiofrequency ablation (RFA) uses heat delivered through a needle tip to destroy nerve tissue. For genicular (knee) nerve pain, a study comparing the two found that both methods provided effective relief at one week, one month, and three months. At three months, about half the patients in each group had achieved at least 50% pain relief. However, temporary paresthesia (tingling or abnormal sensation) was far more common with phenol, occurring in about a third of phenol patients versus 6% of RFA patients.21PubMed Central. Comparison of the efficacy of genicular nerve phenol neurolysis and radiofrequency ablation for pain management in patients with knee osteoarthritis
A separate controlled study in patients with pain after knee replacement surgery told a somewhat different story. At one, three, and six months, pain scores were significantly lower in the phenol group compared to the RFA group. By six months, about 44% of phenol patients still had at least 50% pain relief versus roughly 19% in the RFA group.22PubMed. Comparison of the Effects of Phenol Neurolysis and Conventional Radiofrequency Thermocoagulation Applied to the Genicular Nerves on Pain in Patients Who Underwent Knee Arthroplasty The conflicting results between studies likely reflect differences in patient populations, injection technique, and phenol concentration. For clinicians, this means neither treatment is universally superior; the right choice depends on the individual situation.
Phenol Versus Alcohol for Cancer Pain
Ethanol (alcohol) is the other major neurolytic agent. For celiac plexus neurolysis, a retrospective comparison found that patients in the alcohol group had lower pain scores than those in the phenol group.23Genel Tıp Dergisi. Comparison of the Effects of Alcohol and Phenol Used for Celiac Neurolysis with Endoscopic Ultrasound in Patients with Pancreas Cancer: Retrospective Analysis However, the earlier pilot study in alcohol-intolerant patients found that phenol achieved similar pain relief to ethanol, suggesting phenol is a viable substitute when alcohol cannot be used.2PubMed Central. Phenol-based endoscopic ultrasound-guided celiac plexus neurolysis for East Asian alcohol-intolerant upper gastrointestinal cancer patients: a pilot study Both agents work, and the choice sometimes comes down to patient factors rather than clear superiority of one chemical over the other.
Phenol in Children With Cerebral Palsy
Children with spastic cerebral palsy represent one of the populations where phenol has the longest track record. Spasticity in these children can affect many muscle groups, and the cost of treating all of them with botulinum toxin alone can be prohibitive. A retrospective review of children undergoing multi-level chemoneurolysis sessions found that 72% of sessions used a combination of botulinum toxin and 5% phenol. The overall rate of unintended effects was about 21%, but the majority of those were temporary weakness, which is actually the intended pharmacologic action of the drugs taken slightly further than desired. Transient pain occurred in about 7% of combined-agent sessions. No cases of dysesthesia were reported, and the complication rate did not differ between children who received the combination versus those who received botulinum toxin alone.24PubMed. A Retrospective Review of Unintended Effects After Single-Event Multi-Level Chemoneurolysis With Botulinum Toxin-A and Phenol in Children With Cerebral Palsy
A separate pediatric safety study confirmed that repeat injections of phenol did not lead to accumulating complications over time.17American Journal of Physical Medicine & Rehabilitation. Safety Profile of Multilevel Chemical Denervation Procedures Using Phenol or Botulinum Toxin or Both in a Pediatric Population For families weighing options, the practical takeaway is that phenol combined with botulinum toxin allows broader treatment coverage per session with an acceptable safety profile, though botulinum toxin alone may produce better functional results when treating a limited number of muscle groups.
Phenol Beyond Pain Management
Phenol’s tissue-destroying properties have found uses well outside the pain clinic. One of the most common is chemical matricectomy for ingrown toenails. After the problematic edge of the nail is removed, phenol is applied to the nail matrix (the tissue that grows the nail) to prevent that strip from regrowing. A randomized trial comparing phenol matricectomy to surgical aesthetic reconstruction found a low recurrence rate of about 3% for the phenol method, which was not significantly different from the surgical approach. The trade-off was a longer healing time, averaging about 21 days versus 8 days for surgery, and a somewhat higher infection rate at roughly 6% versus 1.5%.25PubMed Central. The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial For an ingrown toenail that keeps coming back, the phenol procedure is quick, can be done in a regular office visit, and has been a reliable standby in podiatry for decades. The extended healing time and occasional weepy wound in the first few weeks are the main downsides patients should expect.
Phenol also sees use in cosmetic dermatology as a deep chemical peel agent and in certain surgical contexts for tissue cauterization, though those applications are further removed from the pain management landscape and involve different concentrations and techniques entirely.
Who Should Think Twice
Phenol injections are not appropriate for everyone. Because the chemical destroys nerve tissue indiscriminately, injecting it near a mixed nerve (one carrying both motor and sensory fibers) can knock out muscle control along with pain signals. This is why the best targets tend to be either purely sensory nerves or motor nerves in muscles that are already too tight to function. Injecting phenol near a nerve that you need working normally can create a new problem worse than the one you started with.
People with bleeding disorders or active infections near the injection site are generally excluded. Phenol is also best avoided in areas with limited tissue to absorb the chemical, since leakage into surrounding structures can cause tissue necrosis. The case report of severe necrosis and infection following a genicular nerve phenol injection is a reminder that even well-established procedures can go wrong when anatomy or technique is not ideal.13PubMed Central. Adverse Reactions to Phenol Neurolysis: Report of Severe Necrosis and Infection Following Genicular Nerve Ablation
If you are being offered a phenol injection, the questions worth asking your provider include which nerve is being targeted, whether it carries motor fibers you need, what guidance method will be used, and what the plan is if the effect wears off sooner than expected. Clinicians experienced with phenol neurolysis tend to have strong opinions about which nerves respond best and which are better served by other techniques. The evidence suggests that in skilled hands, with proper imaging guidance, phenol remains a useful and cost-effective tool that fills gaps left by pricier or shorter-acting alternatives.